Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
BUHLMANN Laboratories Announces New, Direct US Affiliate
BÜHLMANN Laboratories is proud to announce the establishment of its North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - November 16, 2015 - BUHLMANN Diagnostics Corp
Rite Aid First U.S. Drugstore Chain to Offer Harmonyx Genetic Testing to Customers
Tests help determine most effective medication therapy based on an individual’s genetic makeup - November 12, 2015 - Harmonyx Diagnostics
Visibility Magazine Partnered with SMI Group, Announces: Cutting Edge Digital Strategy Discussed by Leading Pharmaceutical Marketing Practitioners
Online Industry Gathers in Two Weeks for 8th Annual Congress on Social Media in the Pharmaceutical Industry - November 12, 2015 - topseos.com
New Acid Catalyst Offers Significant Cost Reductions with Increased Stability
An exciting new acid catalyst from PhosphonicS could help significantly reduce costs and minimise losses in the Pharmaceutical and Chemical industries. The recently launched Phos-Cat4 has been specially designed to be just as effective as the rest of the PhosphonicS acid catalyst range but offer... - November 12, 2015 - PhosphonicS
Preliminary List of Attendees Released for Cold Chain Distribution 2015
SMi have released the preliminary list of attendees for the 10th annual Cold Chain Distribution Conference and Exhibition being held on 3rd – 4th December in London. - November 12, 2015 - SAE Media Group
Clinigen Group and United Therapeutics Initiate Managed Access Program for UNITUXIN™ (Dinutuximab) Injection for High Risk Neuroblastoma
Clinigen Group plc’s (AIM: CLIN, ‘Clinigen’ or the ‘Group’) Idis Managed Access (MA) division and United Therapeutics Corporation (‘United Therapeutics’), a biotechnology company focused on the development and commercialization of products for chronic and... - November 06, 2015 - Clinigen Group
Cold Chain Distribution 2015: SMi Releases Exclusive Interviews with World Courier, Sanofi Genzyme and American Airlines Cargo
SMi Reports (2015.11.03, London): SMi caught up with the key speakers for Cold Chain Distribution 2015 for exclusive interviews ahead of the conference. - November 05, 2015 - SAE Media Group
Compounding Pharmacies Market to Grow at a CAGR of 5.7% Between 2015 and 2021; Future Market Insights
Future Market Insights has announced the addition of the "Compounding Pharmacies Market: U.S. Industry Assessment and Forecast; 2015–2021" report to their offering. - November 04, 2015 - Future Market Insights
New GCP Training with Certificate from Pharma Lessons
The long awaited certificate GCP training course from Pharma Lessons is finally out. It is a beautifully designed online package put together by a team of renowned pharma industry experts. - October 31, 2015 - Pharma Lessons
Tabula Rasa HealthCare Responds to CMS Announcement of Part D Enhanced Medication Therapy Managment Model
Under the CMS Enhanced MTM Model, the personalized MTM services offered by Tabula Rasa HealthCare are now eligible for reimbursement by CMS, and for additional performance-based payments. TRHC's Medication Risk Mitigation Matrix(TM) has proven to reduce adverse drug reactions. - October 29, 2015 - Tabula Rasa HealthCare
Registration Now Live for SMi’s 10th annual Parallel Trade Conference
SMi Group Reports (23.10.2015): SMi proudly presents its 10th annual conference on Parallel Trade held in London on the 8th to the 9th February 2016. - October 25, 2015 - SAE Media Group
Clinical Trials in Russia. The Third Quarter 2015.
The Ministry of Health of the Russian Federation approved 203 new clinical trials of all types, including local and bioequivalence studies, during the 3rd Quarter of 2015. This represents a 13% increase over the same period of last year. - October 25, 2015 - Synergy Research Group
Genzyme and Novartis Pharma to Unveil the Challenges of Pharma Distribution in Emerging Markets and Extreme-Temperature Zones in London in December
SMi Reports: Cold Chain Distribution 2015: Enhance Temperature Management for an Efficient Supply Chain. - October 24, 2015 - SAE Media Group
Human Factors Engineering in Pre-Filled Syringes to be Addressed by Amgen, MHRA, F.Hoffman-La Roche and Medical Device Usability at Pre-Filled Syringes 2016 in London
SMi Reports: Pre-Filled Syringes 2016: The A-Z Guide to develop a safe, patient-centric and commercially viable drug delivery device. - October 22, 2015 - SAE Media Group
Source One’s Data Scientist Brings the Future of Spend Management to Tomorrow's Business Leaders
Adding to an already jam-packed Quarter 4, noted Procurement Services Provider, Source One Management Services, LLC, continues its educational outreach with a speaking engagement at La Salle University. Source One Data Scientist, James Patounas will be the featured speaker at the October 2015... - October 20, 2015 - Source One, a Corcentric Company
Oak Street Health and Tabula Rasa Healthcare Aim to Improve Patient Outcomes Through Optimization of Medication Regimens
Program's goal is to improve the safety of patient medication regimens and patient outcomes using Tabula Rasa's novel and proprietary MRM technolgy platform in tandem with the automated, robotic dispensary of TRHC's CareKinesis Pharmacy. - October 15, 2015 - Tabula Rasa HealthCare
European Pre-Filled Syringes Market: Latest updates from GSK R&D, Sanofi R&D, Amgen, MHRA, F.Hoffmann-La Roche Ltd, Novartis Pharma AG, Barts Health Pharmaceuticals
SMi Reports (2015.10.13, London): Leading drug delivery experts will gather in London next January to discuss the upcoming obstacles and the solutions which can be explored to accelerate pre-filled syringes development and technology advancements. - October 15, 2015 - SAE Media Group
Gensco Laboratories Supports World Arthritis Day on October 12, 2015
Gensco Laboratories, a specialty pharmaceutical company, has recently introduced a new transdermal prescription medication that provides rapid relief at the first sign of an acute gout flare, ColciGel®, indicated for the treatment and prophylaxis of acute gout flares in adults. ColciGel® is easy to apply directly on the site of pain and each bottle has Metered Dose Technology (MDose™) which dispenses the exact amount of transdermal medication. - October 12, 2015 - Gensco Labs
CHI to Host Roundtable Discussions at Optimizing Bioassays for Biologics Conference
Moderated by Drs. Han Li, Bristol-Myers Squibb; Maura C. Kibbey, United States Pharmacopeia (USP); and Max L. Tejada, Gilead Sciences - October 10, 2015 - Cambridge Healthtech Institute
Visibility Magazine Along with SMi Group Announces - The Social Media Doctor: Pharmaceutical Industry Enters Into a New and Exciting Digital Era in 2016
Solidifying digital strategy to enhance patient engagement at SMi Group's 8th annual conference on Social Media in the Pharmaceutical Industry - October 09, 2015 - topseos.com
New Research Identifies Leading Clinical CROs Best Positioned for Future Success
New Research Identifies Future Leadership and Benchmarks CRO Operational Performance with over 160 Clinical Outsourcing Decision Makers - October 07, 2015 - Life Science Strategy Group, LLC
Recursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder
Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a hereditary stroke disease. Recursion expects this will be the first of many potential treatments identified using their proprietary drug discovery platform. - October 05, 2015 - Recursion Pharmaceuticals
23rd SAPA Annual Conference “Advancing Breakthrough Medicines Through Global Innovation and Partnership”
On September 12th, 2015, SAPA (Sino-American Pharmaceutical Professionals Association) hosted its 23rd Annual Conference at Princeton University, McDonnell Hall. The conference was a huge success and attracted around 500 experts and professionals from both Pharmaceutical and Biotech industry and... - October 01, 2015 - Sino-American Pharmaceutical Professionals Association
Ixogel® is Granted QIDP Status by the US Food and Drug Administration
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the U.S. Food and Drug Administration (FDA) has designated the company's lead product candidate, Ixogel®, as a Qualified Infectious Disease Product (QIDP) for the prevention of Lyme Disease after a tick bite and is working with the company on the phase III protocol. Special Protocol Assessment (SPA) confirmation expected soon. - September 29, 2015 - Ixodes AG
Mayne Pharma's New $65M Facility Will Double U.S. Manufacturing Capacity, Expand Contract Services
At an event celebrating the start of construction, Mayne Pharma shared new details about its planned $65-million, 126,000-square-foot oral-dose facility in Greenville, N.C. The new facility will double the company's U.S. manufacturing capacity and introduce commercial-scale fluid-bed processing capacity for modified-release bead/pellet drugs. Space within the company's existing facility will be repurposed to expand contract analytical and formulation development services offered by Metrics. - September 26, 2015 - Mayne Pharma USA
EMLab P&K Helps Mold Testing Specialists in New York and Maryland Through Patent-Pending Lab Report
Mold testing specialists in New York and Maryland gain enhanced insights for their mold inspections through MoldRANGE Local Climate reports. Mold lab report provides better insights for outdoor mold spore levels based on the project’s zip code. - September 23, 2015 - EMLab P&K IAQ Laboratory
Ben W. Surette Recognized by Strathmore's Who's Who Worldwide Publication
Ben W. Surette of Manalapan, New Jersey has been included in the Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of advertising. About Ben W. Surette Mr. Surette has over 12 years experience with his current company. He is Vice... - September 19, 2015 - Strathmore Worldwide
Enzymes Market is Expected to Reach $5.4 Billion, Worldwide, by 2020
According to a new report by Allied Market Research titled, "World Enzymes Market -Opportunity and Forecast, 2014-2020," the world enzymes market is expected to register a CAGR of 7.8% during 2015-2020. The household care segment holds about 1/3rd of the overall market share in 2014, due... - September 18, 2015 - Allied Market Research
Specialty Enzymes Market is Expected to Reach $947.5 Million, by 2020
According to a new report by Allied Market Research titled, "World Specialty Enzymes for Pharmaceuticals, Biotechnology R&D and Diagnostics - Market Opportunity and Forecast, 2014-2020," the global specialty enzymes market is expected to register a CAGR of 9.4% during 2015-2020. The... - September 18, 2015 - Allied Market Research
MD Anderson, Cayman Chemical, and Fannin Innovation Studio Form Therapeutics Company
The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of... - September 17, 2015 - Cayman Chemical Company
World Compliance Seminar and Morf Media Inc. Host 3rd FDA Inspection Seminar with a Risk Driven Approach Dec 3-4 Boston, MA
World Compliance Seminars today announced a live seminar on Food and Drug Administration (FDA) inspection procedures. The seminar, conducted by Chief Compliance officer Angela Bazigos, takes place in Boston, MA. - September 09, 2015 - World Compliance Seminars
Innovative Solutions Announces Contract with Massachusetts Medical Cannabis Grower
Innovative Solutions, a microbial and pathogen sanitization specialist for the cannabis industry today announced it has secured a contract to design and install state-of-the-art Sanitization Technology air & surface purification technology throughout their customer’s 50,000 Sf cannabis... - September 07, 2015 - Innovative Solutions
VIRUN® NutraBIOsciences™ Relocates R&D to Pomona, Presenting at Upcoming Cognitive Health Online Summit, Exhibiting at SupplySideWest & Announces VIRUN T-Shirt Trend
The Cognitive Health Online Summit will occur on September 2, 2015, and will feature Philip Bromley discussing Smart Delivery Technologies. VIRUN signs a lease for a new R&D facility in Pomona, California. SupplySide West Expo 2015 is right around the corner, and VIRUN is sure to be a crowd pleaser as it goes back in time to deliver the future of functional beverages. VIRUN has added a “Shop VIRUN” page to proliferate the VIRUN phenomenon. - September 01, 2015 - VIRUN
KinderPharm LLC Acquires Clinical Pharmacology and Pharmacometric Research and Development Company
KinderPharm LLC., announced that it has acquired PKPD Bioscience, Inc., a clinical pharmacology and pharmacometric research and development company. The purchase will strengthen the capabilities of KinderPharm LLC to provide pediatric PK/PD modeling and simulation as well as Pop PK and sparse sampling. - September 01, 2015 - KinderPharm LLC
Keynote Line-Up and Seven FDA Speakers Confirmed for Immunogenicity and Bioassay Summit 2015, Organized by Cambridge Healthtech Institute
Seventh annual event to focus on technologies and strategies for safe and efficacious products in the clinic. - August 31, 2015 - Cambridge Healthtech Institute
Mayne Pharma to Invest $65m in Major Manufacturing Expansion in North Carolina
The company will invest $65 million to significantly expand facilities and equipment at its site in Greenville, N.C. Plans include greenfield construction of a new, 126,000-square-foot oral-dose commercial manufacturing facility, doubling U.S. manufacturing capacity, plus re-urposing of existing space to expand contract services. - August 29, 2015 - Mayne Pharma USA
Social Media Expert Matt Rubin Presents at Always Best Care International Conference
Matt Rubin, social media expert and President of Charleston-based MR. Marketing, presented “Social Media and Strategic Online Brand Development” at Always Best Care Senior Service’s 4th International Conference in San Antonio, Texas. Mr. Rubin’s presentation covered a wide... - August 28, 2015 - Always Best Care
42 market research Announces the Launch of Its Online Healthcare Panel for Pharmaceutical Research in the Czech Republic
42 market research, a leading provider for online market research in the healthcare sector, is pleased to announce the launch of its new healthcare panel for pharmaceutical research in the Czech Republic. - August 25, 2015 - 42 market research
American Retirement Advisors Ranked on the Inc 500 List 2nd Straight Year
For second consecutive year, American Retirement Advisors is ranked 4th fastest-growing company in Arizona and is the N0. 12 fastest growing financial service company in the nation with three year sales growth of 2,228.9%. - August 18, 2015 - American Retirement Advisers
Bispecifics: From Discovery to First in Human Masterclass – Registration Now Live
SMi are proud to announce that registration is now live for the upcoming masterclass entitled: Bispecifics: From discovery to first in human, taking place on the 7th December 2015 in London, UK. - August 16, 2015 - SAE Media Group
KinderPharm Raises $1 Million to Further Advance Pediatric Drug Development
KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $1 million from a Series A comprised of individuals, companies and angel investors. The $1 million investment will be used to further advance the clinical development of new medicines for children. - August 13, 2015 - KinderPharm LLC
ABR Launches Bovine Polyomavirus Testing Service
ABR (now a VMRD division) announced today the availability of a new testing service that can detect the presence of bovine polyomavirus (BPyV) in animal origin products, master virus seeds, and other sample types. This infectivity assay, without using non-infectivity assays such as PCR, has the... - August 12, 2015 - VMRD, Inc.
Gensco Labs Announces LiDORx® Copay Program Mobile Platform for Pain Management
Text “LIDO to 37500” on your mobile device to receive the benefits of the Program Gensco Laboratories™ (www.genscolabs.com), A Specialty Pharmaceutical Company, announces a new mobile platform that uses innovative smart phone technology to provide copay assistance and facilitate... - August 11, 2015 - Gensco Labs
The Real Story About Rare and Ultra-Rare Disease from the Ultra Rare Diseases, Disorder & Disabilities Foundation
SMi Group reports (2015.08.07 – London, UK): The Ultra Rare Diseases, Disorder & Disabilities Foundation will attend the 4th annual Orphan Drugs and Rare Diseases Conference, to present “The real story about rare and ultra-rare disease.” - August 11, 2015 - SAE Media Group
ADC Contract Manufacturing Market: Opportunities Ahead
Antibody Drug Conjugates (ADCs) are a new class of therapeutic drugs consisting of a cytotoxic drug linked to a monoclonal antibody. These novel conjugates are believed to be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. - August 10, 2015 - Roots Analysis
Pinnacle 21 CEO Max Kanevsky Named to PharmaVOICE 100
Pinnacle 21 announced today that its president & CEO, Max Kanevsky, has been named to the prestigious PharmaVOICE 100 list of the most innovative and influential people in the life-sciences industry. - August 07, 2015 - Pinnacle 21
MHRA to Demonstrate How to Meet the Needs of the EU GDP at Cold Chain Distribution 2015
SMi Group reports: SMi Group are delighted to announce that the MHRA will be presenting at the 10th annual Cold Chain Distribution 2015 in London - August 07, 2015 - SAE Media Group
Leaders in the Biosimilar Sector - Sandoz, Oncobiologics, Merck, Samsung Bioepis - Will Meet at Biosimilars & Biobetters USA 2015
SMi Group reports: Leading organizations in the Biosimilars Development sector will meet at Biosimilars and Biobetters USA 2015 – the must-attend premier industry event which will take place in Iselin this November. - August 07, 2015 - SAE Media Group
Global Home Infusion Therapy Devices Market: High Prevalence of Chronic Diseases to Lead Market to Register 9% CAGR by 2020
This report provides in-depth analysis and estimation of the home infusion therapy devices market for the period 2014–2020, considering 2014 as the base year for the calculation. - August 06, 2015 - Persistence Market Research
Ryan’s Quest Clinical Trial Grant for Steroid Alternative
The Ryan’s Quest Foundation, a non-profit organization specific to Duchenne muscular dystrophy, announced today the award of their most recent contribution toward the fight to end Duchenne muscular dystrophy. The Foundation has awarded ReveraGen BioPharma $50,000 towards a clinical trial for... - August 04, 2015 - Ryan's Quest